Holocene Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,802
Closed -$2.6M 832
2024
Q3
$2.6M Sell
7,802
-1,742
-18% -$662K 0.01% 505
2024
Q2
$3.93M Buy
9,544
+1,390
+17% +$550K 0.02% 374
2024
Q1
$3.3M Buy
8,154
+1,421
+21% +$500K 0.01% 492
2023
Q4
$2.06M Buy
6,733
+206
+3% +$55.6K 0.01% 527
2023
Q3
$1.58M Buy
+6,527
New +$1.67M 0.01% 593
2023
Q1
Sell
-3,930
Closed -$835K 820
2022
Q4
$835K Sell
3,930
-3,904
-50% -$780K 0.01% 579
2022
Q3
$1.23M Buy
+7,834
New +$1.25M 0.01% 573
2022
Q2
Sell
-5,491
Closed -$898K 926
2022
Q1
$898K Buy
+5,491
New +$905K ﹤0.01% 712

Other funds holding MEDP

Holocene Advisors's MEDP Position: Q4 2024 in Review

Holocene Advisors sold out of Medpace (MEDP) in Q4 2024, closing a stake of 7,802 shares — an estimated $2.6M sold.

Holocene Advisors first reported a position in MEDP in Q1 2022 and held it in 8 quarters. The position peaked at $3.93M in Q2 2024. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

  • Holocene Advisors reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
  • Holocene Advisors sold 7,802 Medpace shares in Q4 2024, an estimated $2.6M.
  • Holocene Advisors first reported a position in Medpace in Q1 2022 and held it in 8 quarters.
  • Holocene Advisors's Medpace position peaked at $3.93M in Q2 2024.
  • 592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on Holocene Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.